CATIE phase 2 tolerability study results show high treatment discontinuation rates
Landmark STAR*D study highlights value of augmentation, switching
No pharmacokinetic interaction found between lamotrigine and olanzapine
Reboxetine versus fluvoxamine for PTSD
Reboxetine versus citalopram for MDD
Risperidone in children, adolescents and adults with MR
Editor's Note
News Notes
Topiramate plus paroxetine in treatment-resistant OCD
From the FDA